Clinical Trial: A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants

U.S., Feb. 27 -- ClinicalTrials.gov registry received information related to the study (NCT06846866) titled 'A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants' on Feb. 21.

Brief Summary: The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of BMS-986419 (Part 1) and the effects of multiple doses of BMS-986419 on cardiac repolarization (Part 2) in healthy participants.

Study Start Date: Feb. 25

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: BMS-986419

Specified dose on specified days

DRUG: BMS-986419 Matching Placebo

Specifie...